03 · Managing partners

Commercialization experience, invested.

RCP Venture Capital is led by the co-founders of Rapid Commercialization Partners — a women-led team bringing biotech commercialization, business development and private-market experience to every investment.
Portrait of Christina J. Ansted

Managing Partner & Co-Founder

Christina J. Ansted, MPH, CCMEP

Also Co-Founder & CEO, Rapid Commercialization Partners

Christina is a seasoned biotechnology executive with deep experience guiding emerging life sciences companies through complex commercialization challenges. She brings a rigorous, outcomes-focused approach to strategy and execution, helping organizations optimize readiness, build high-performing teams, and accelerate the path from development to market.

Her background spans global commercialization and marketing, shared medical services, and medical and scientific communications, with particular strength in patient identification, diagnostic strategy, and launch planning. Christina is driven by a commitment to improving the success rate of innovative therapies and advancing meaningful treatments to patients more efficiently.

Portrait of Michael C. Janes

Managing Partner & Co-Founder

Michael C. Janes

Also Co-Founder & CRO, Head of Private Market Practice, Rapid Commercialization Partners

Michael is an experienced business development and life sciences executive with deep expertise in driving growth, strategic partnerships, and commercialization success across biotech. At RCP Venture Capital he bridges the gap between innovative science and commercial viability by aligning visionary founders with capital, operational resources, and go-to-market expertise.

With extensive experience alongside emerging and mid-stage companies, Michael builds strategic collaborations with venture capital and private equity investors to accelerate clinical-stage innovation and unlock value at key inflection points — bringing commercial strategy, investor relations, and operational leadership to every engagement.

Venture partner & advisors

An integrated operating network.

Supporting diligence, commercialization readiness, and post-investment value creation alongside the managing partners.

David Hendren

Venture Partner

David Hendren, JD

  • 25+ years launching, financing, and building healthcare and life sciences ventures from incubation to exit, as VC, founder, CEO, board chair, and counsel
  • Managing Director of Augmentum Ventures (Augmentum Advisors); co-founder and General Partner of Catalyst Health & Technology Partners
  • Led and co-invested alongside top-tier firms and strategics, with exits including IPO, M&A, and licensing; former corporate law partner focused on start-ups, finance, and M&A
Dirk Richter

Strategic Advisor – Middle East

Dr. Dirk Richter, MD, PhD

  • 25+ years bridging clinical medicine, health system leadership, and life sciences innovation across Europe, the GCC, and beyond
  • Former senior roles with the Abu Dhabi Department of Health and the UAE Presidential Court, and Advisor to the UAE Minister of Health and Prevention
  • Partners with investors, family offices, and healthtech companies to turn promising health technologies into scalable, commercially viable businesses
Bibhash Mukhopadhyay

Venture Advisor

Bibhash Mukhopadhyay, PhD

  • Fund manager, investor, and company builder with nearly two decades in biotech; Founder and CEO of Sapient Biotech Investments
  • Former co-founder and Managing Partner of Sound Bioventures, and investor in NEA’s biotech practice
  • Operating experience at AstraZeneca and Johnson & Johnson; board director at private and public companies across the US and Europe

Founders · Co-investors · LPs

Advancing through the clinic? Let’s talk.

The quickest way to reach the partners is LinkedIn. Send a note about your company, your next milestone, and what it would unlock.